Regulation of BRCA1 by protein degradation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Oncogene

• Publication date

  1999-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203068PMID 10597248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter

  1999cited by this paper
• A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

  1999cited by this paper
• An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.

  1999cited by this paper
• Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome.

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Calpain: a protease in search of a function?

  1998cited by this paper
• Stabilization of wild-type p53 by hypoxia-inducible factor 1α

  1998cited by this paper
• Ubiquitin, E6-AP, and their role in p53 inactivation.

  1998cited by this paper
• Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.

  1998cited by this paper
• Lactacystin, Proteasome Function, and Cell Fate*

  1998cited by this paper
• A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle

  1998cited by this paper
• A cytosolic activity distinct from crm1 mediates nuclear export of protein kinase inhibitor in permeabilized cells.

  1998cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• BRCA1 and BRCA2: from molecular genetics to clinical medicine.

  1998cited by this paper
• Intracellular Proteolytic Cleavage of 9-cis-Retinoic Acid Receptor α by Cathepsin L-type Protease Is a Potential Mechanism for Modulating Thyroid Hormone Action*

  1998cited by this paper
• Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents

  1998cited by this paper
• A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1.

  1997cited by this paper
• Family studies and the evidence for genetic susceptibility to prostate cancer.

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• CRM1 is responsible for intracellular transport mediated by the nuclear export signal

  1997cited by this paper
• Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts

  1997cited by this paper
• CRM1 is an export receptor for leucine-rich nuclear export signals.

  1997cited by this paper
• Proteolysis by calpains: a possible contribution to degradation of p53

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cited by this paper
• Double indemnity: p53, BRCA and cancer

  1997cited by this paper
• Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition

  1997cited by this paper
• On the involvement of calpains in the degradation of the tumor suppressor protein p53

  1997cited by this paper
• Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo

  1997cited by this paper
• Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability

  1997cited by this paper
• Loss of function and p53 protein stabilization

  1997cited by this paper
• Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.

  1997cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.

  1996influential reference
• Selective uptake and degradation of c‐Fos and v‐Fos by rat liver lysosomes

  1996cited by this paper
• In vivo ubiquitination and proteasome-mediated degradation of p53(1).

  1996cited by this paper
• Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

  1996cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

  1995influential reference
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Hormone-dependent regulation of BRCA1 in human breast cancer cells.

  1995cited by this paper
• Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

  1994cited by this paper
• DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

  1994cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes.

  1985cited by this paper
• Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

  1984cited by this paper

• β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

  2025cites this paper
• Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Unravelling the Network of Nuclear Matrix Metalloproteinases for Targeted Drug Design

  2020cites this paper
• Bioinformatics and Molecular Analysis of the Breast Cancer Susceptibility Gene BRCA1 in Breast Cancer

  2020cites this paper
• USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells

  2019cites this paper
• Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance

  2019cites this paper
• Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B‐mediated degradation of BRCA1

  2018cites this paper
• NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair

  2018cites this paper
• Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation

  2018cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Breast cancer 1 (BRCA1)-deficient embryos develop normally but are more susceptible to ethanol-initiated DNA damage and embryopathies☆

  2015cites this paper
• Biomarcadores predictivos de respuesta al tratamiento en cáncer de mama por inmunohistoquímica

  2014cites this paper
• Nuclear localization of catalytically active MMP-2 in endothelial cells and neurons.

  2014cites this paper
• BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells

  2013cites this paper
• A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing*

  2013cites this paper
• A New Pathway Responsible For 53BP1 Loss in Breast Cancer and Laminopathies

  2012cites this paper
• Activation of the BRCA1/Chk1/p53/p21(Cip1/Waf1) pathway by nitric oxide and cell cycle arrest in human neuroblastoma NB69 cells.

  2012cites this paper
• The C-terminal Proteolytic Fragment of the Breast Cancer Susceptibility Type 1 Protein (BRCA1) Is Degraded by the N-end Rule Pathway*

  2012cites this paper
• NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes

  2011cites this paper
• Fanconi anemia D2 protein is an apoptotic target mediated by caspases

  2011cites this paper
• BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells.

  2010cites this paper
• Novel Roles for 185delAG Mutant BRCA1 in Ovarian Cancer Pathology

  2010cites this paper
• Identification and Characterization of Novel Kinases that Regulate BRCA1 Expression and Function

  2010cites this paper
• Use of novel assays to measure in vivo base excision DNA repair

  2009cites this paper
• BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells

  2009cites this paper
• Does the nonsense‐mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

  2008cites this paper
• Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis

  2008cites this paper
• Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism?

  2008cites this paper
• Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors

  2007cites this paper
• Hypermethylation of the Breast Cancer–Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk

  2007cites this paper
• Gene expression profiling of primary cutaneous melanoma and clinical outcome.

  2006cites this paper
• Gene Expression Pro fi ling of Primary Cutaneous Melanoma and Clinical Outcome

  2006cites this paper
• Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

  2005cites this paper
• Nedd4-2 Phosphorylation Induces Serum and Glucocorticoid-regulated Kinase (SGK) Ubiquitination and Degradation*

  2005cites this paper
• Verge: A Novel Vascular Early Response Gene

  2004cites this paper
• Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression*

  2004cites this paper
• Nuclear architecture and gene expression in the quest for novel therapeutics.

  2004cites this paper
• Decreased p21 Levels Are Required for Efficient Restart of DNA Synthesis after S Phase Block*

  2004cites this paper
• A Functional Genomics Approach to Identify Novel Breast Cancer Gene Targets in Yeast

  2004cites this paper
• Untersuchungen zur Rolle des HIV-1-Tat-Proteins in der AIDS-assoziierten Vaskulopathie

  2003cites this paper
• Effects of the Phytoestrogens Genistein and Daidzein on BRCA2 Tumor Suppressor Gene Expression in Breast Cell Lines

  2003cites this paper
• Role of proteasomes in the degradation of short-lived proteins in human fibroblasts under various growth conditions.

  2003cites this paper
• BRCA1 gene in breast cancer

  2003cites this paper
• Role of BRCA1 in heat shock response

  2003cites this paper
• Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells.

  2003cites this paper
• An adenoviral vector containing an arg–gly–asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression

  2003cites this paper
• Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines

  2003cites this paper
• Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus

  2003cites this paper
• Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

  2002cites this paper
• Gene Expression Profiling of Testosterone and Estradiol-17β-Induced Prostatic Dysplasia in Noble Rats and Response to the Antiestrogen ICI 182,780.

  2002cites this paper
• Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines

  2002cites this paper
• Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780.

  2002cites this paper
• [Update on . . . the proteasome inhibitor PS341].

  2002cites this paper
• BRCA1 methylation: a significant role in tumour development?

  2002cites this paper
• Reduced Brca1 protein expression in 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine–induced rat mammary carcinomas

  2002cites this paper
• Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control

  2002cites this paper
• A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining

  2002cites this paper
• Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis

  2002cites this paper
• Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking

  2002cites this paper
• Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine1

  2002cites this paper
• Regulation of BRCA1 expression and its relationship to sporadic breast cancer

  2002cites this paper
• Chloroquine antagonizes the proinflammatory cytokine response to opportunistic fungi by alkalizing the fungal phagolysosome.

  2001cites this paper
• A Transcriptionally Inactive E2F-1 Targets the MDM Family of Proteins for Proteolytic Degradation*

  2001cites this paper
• Ultraviolet radiation alters the phosphorylation of RNA polymerase II large subunit and accelerates its proteasome-dependent degradation.

  2001cites this paper
• Palmitoylation-dependent Control of Degradation, Life Span, and Membrane Expression of the CCR5 Receptor*

  2001cites this paper
• Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors

  2001cites this paper
• Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

  2000cites this paper
• Chloroquine Interferes with Lipopolysaccharide-Induced TNF-α Gene Expression by a Nonlysosomotropic Mechanism1

  2000cites this paper
• Repression of BRCA1 through a Feedback Loop Involving p53*

  2000cites this paper
• BRCA1 is Overexpressed in Breast Cancer Cell Lines and is Negatively Regulated by E2F6 in Normal but not Cancerous Breast Cells

  year unknowncites this paper